News Center
Home > News Center > Content
China's first diagnostic reagent for liver cancer with full intellectual property rights developed by USC
2022-03-01 09:57  

Recently, a new diagnostic kit for primary liver cancer developed by Professor Cao Deliang of University of South China has been approved by the National Medical Products Administration for the registration of Category 3 of diagnostic reagents.

This is the first liver cancer diagnostic kit with completely independent intellectual property rights in China, which can help early asymptomatic patients with liver cancer to achieve early diagnosis and treatment.

Close Window

Copyright © 2010 University of South China